Current stock page

Financial Data

BRKR Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

BRKRBruker Corporation

Healthcare / Medical - Devices

Low Priority

Above Peers

NeutralEdge 7/10
$63.26+$1.90 (+3.10%)

Latest quote

  • Momentum
    83
  • Value
    53
  • Quality
    60
  • Risk resilience
    44
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$874M
+1.6% YoY
Net income
-$111.8M
−87.6% YoY
Free cash flow
$96.7M
+278.7% YoY
Operating margin
-10.4%
−14.5 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

BRKR, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+1.6%$874M$839M$823M$977M$861M$797M$801M$980M
Gross profit+13.2%$429M$416M$389M$449M$379M$358M$391M$493M
Operating income−360.0%−$91M−$65M$45M$112M$35M$12M$32M$72M
Net income−87.6%−$112M−$52M$14M$26M−$60M$8M$17M$14M
EPS (diluted)−97.6%−$0.81−$0.41$0.02$0.10−$0.41$0.05$0.11$0.09
Gross margin+5.0 pts49.1%49.6%47.3%46.0%44.1%44.9%48.8%50.4%
Operating margin−14.5 pts-10.4%-7.8%5.5%11.4%4.1%1.5%4.0%7.4%
Net margin−5.9 pts-12.8%-6.2%1.7%2.7%-6.9%1.0%2.2%1.4%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow+456.0%$118M−$77M$71M$230M−$33M−$128M$65M$190M
Capital expenditure−2.9%−$22M−$29M−$24M−$23M−$21M−$21M−$26M−$37M
Free cash flow+278.7%$97M−$106M$47M$207M−$54M−$149M$39M$153M
Free cash flow margin+17.4 pts11.1%-12.7%5.7%21.2%-6.3%-18.7%4.9%15.6%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets−9.4%$5.83B$6.05B$6.13B$6.24B$6.43B$6.34B$5.93B$5.81B
Total liabilities−11.6%$3.49B$3.63B$3.63B$3.73B$3.94B$4.47B$4.08B$3.99B
Shareholders' equity−6.0%$2.29B$2.40B$2.45B$2.46B$2.43B$1.80B$1.82B$1.78B
Total debt−14.7%$1.71B$1.92B$1.67B$2.04B$2.01B$2.44B$2.11B$2.25B
Cash and equivalents−59.2%$120M$185M$133M$299M$293M$92M$184M$183M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/B ratio+1.333.843.332.732.492.512.703.413.99
Return on equity−4.5 pts-5.4%-3.0%-0.5%-0.4%-0.9%4.4%4.4%6.3%
Debt to equity−0.080.750.800.680.830.831.351.161.26
Free cash flow yield+2.9 pts2.8%1.2%0.8%0.7%-0.2%1.0%2.8%1.9%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio-55.83x
P/B ratio4.09x
Revenue growth (YoY)1.57%
EPS growth (YoY)-97.56%
Gross margin47.93%
Operating margin0.01%
ROE-5.15%
ROIC0.01%
Debt to equity0.75
FCF yield2.61%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$63.26
Volume
As of Nov 13, 2026
2.02M
RSI (14)
As of Nov 13, 2026
52.52
MACD
As of Nov 13, 2026
0.84
MACD signal
As of Nov 13, 2026
0.55
MACD histogram
As of Nov 13, 2026
0.29
ADX (14)
As of Nov 13, 2026
26.29
SMA (50)
As of Nov 13, 2026
$59.48
SMA (200)
As of Nov 13, 2026
$50.82
ATR (14)
As of Nov 13, 2026
$3.81
Historical volatility (annualized)
As of Nov 13, 2026
84.42%
Volume (20-day average)
As of Nov 13, 2026
2.62M
Risk measures
MetricValue
Resilience score44/100
Beta1.73
Annual volatility59.79%
Max drawdown-39.85%
Sharpe ratio0.89
VaR (95%, 1-day)-4.76%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

BRKR Financial Data FAQ

What is Bruker Corporation's revenue?

Bruker Corporation's revenue is one of the core financial data points for BRKR. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Bruker Corporation's revenue growing?

Revenue growth shows whether Bruker Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is BRKR's EPS?

BRKR's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Bruker Corporation's net income?

Bruker Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Bruker Corporation generate?

Free cash flow shows how much cash Bruker Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Bruker Corporation have?

Cash and debt help frame BRKR's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.